KMT2D and neoplasm: Considering common mutations among the different tumor types being evaluated, the TP53 (4 UCS/4 ULMS/3 ESS), ATM (2 ULMS/2 ESS/1 UCS), and KMT2D (1 UCS/1 ULMS/1 ESS) genes could be indicators of similarities in neoplastic progression.